CF
HAE icon

Corebridge Financial’s Haemonetics HAE Stock Holding History

Corebridge Financial’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-79,467
Closed -$5.05M – 1172
2025
Q1 		$5.05M Sell
79,467
-1,965
-2% -$134K 0.03% 686
2024
Q4 		$6.36M Sell
81,432
-5,543
-6% -$445K 0.03% 610
2024
Q3 		$6.99M Sell
86,975
-3,872
-4% -$313K 0.04% 588
2024
Q2 		$7.52M Buy
+90,847
New +$7.99M 0.04% 538

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Corebridge Financial's HAE Position: Q2 2025 in Review

Corebridge Financial sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 79,467 shares — an estimated $5.05M sold.

Corebridge Financial first reported a position in HAE in Q2 2024 and held it in 4 quarters. The position peaked at $7.52M in Q2 2024. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.

  • Corebridge Financial reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 79,467 Haemonetics shares in Q2 2025, an estimated $5.05M.
  • Corebridge Financial first reported a position in Haemonetics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Haemonetics position peaked at $7.52M in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.